The Food and Drug Administration (FDA) said on Nov. 11 that Dr. Richard Pazdur, who had been in charge of regulating cancer drugs, will be the new director of the Center for Drug Evaluation and Research (CDER).
Pazdur has worked at the FDA for 26 years and is the founding director of the FDA’s Oncology Center of Excellence.
His other work at the agency included launching a new way to review cancer products that focused on speeding up the development of novel therapies.
“Dr. Pazdur is a true regulatory innovator who will help guide our broader agenda to modernize the agency and streamline the approval process,” Dr. Marty Makary, the FDA’s commissioner, said in a statement. “He has a track record of success and is an impressive forward-thinking scientist.”…